DETERMINATION OF CANCER ANTIGEN CA15-3 AND ALPHA
FETO PROTEIN (AFP) LEVELS AS TUMOR MARKER IN
PATIENTS WITH BREAST AND PROSTATE CANCER
Rana Kareem Al- Saady, Salah Mohammed Fizea.
Abstract
The objective of the present study is to evaluate the values of cancer antigen (CA15-3) and alpha feto protein (AFP) in patients with breast
and prostate cancer. The results revealed the values for CA 15-3 in serum of G1 showed a highly significant increase compared to normal
healthy subjects, but CA15-3 in serum of G2 was compatible with control. The results showed the value of serum AFP in G1 (was not
significant different) when compared to control, while a highly significant difference in G2 was noticed when compared to healthy subjects.
Key words: CA15-3, AFP, breast cancer, prostate cancer.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
